Latest Breaking News On - ஜான் டெமரி - Page 1 : comparemela.com
Karyopharm Announces Key Changes to Its Commercial Leadership Team
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Karyopharm Announces Key Changes to Its Commercial Leadership Team
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
Karyopharm Therapeutics Inc (KPTI) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble.
Karyopharm Therapeutics Inc (NASDAQ: KPTI)
Popular Searches
Operator
Good morning. My name is Jason, and I ll be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics First Quarter 2021 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the Company s request.
I would now like to turn the call over to Mr. Ian Karp, Karyopharm s Senior Vice President, Investor and Public Relations.SPONSORED:
Operator
Good morning. My name is Vaishnavi, and I ll be your conference operator for today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Fourth Quarter and Full Year 2020 Financial Results Conference Call. There will be a question-and-answer session to follow. [Operator Instructions]
I would now like to turn the call over to Mr. Ian Karp, Karyopharm s Senior Vice President, Investor and Public Relations. Please go ahead.
Ian Karp
Senior Vice President, Investor And Public Relations
Thanks so much. And thank you all for joining us on today s conference call to discuss Karyopharm s fourth quarter and full year 2020 financial results and business update. This is Ian Karp. And I m joined today by Dr. Michael Kauffman, our Chief Executive Officer; Mr. Mike Mason, Chief Financial Officer; Mr. John Demaree, Chief Commercial Officer; Dr. Jatin Shah, Chief Medical Officer; and Mr. Stephen Mitchener, Chief Business Officer. On the call today, Michael